Human papillomavirus vaccine acceptability among young adult men

Sexually Transmitted Diseases

Volumn 36, Issue 1, 2009, Pages 58-62

  Gerend, Mary A ^a   Barley, Jessica ^a  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER RISK; DEMOGRAPHY; HEALTH BELIEF; HEALTH CARE COST; HETEROSEXUAL MALE; HUMAN; MALE; NORMAL HUMAN; PREDICTION; SEXUAL BEHAVIOR; SEXUALITY; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; WART VIRUS; ADOLESCENT; FEMALE; PATIENT ATTITUDE; PATIENT EDUCATION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES, VIRAL; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 59049084525     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31818606fc     Document Type: Article

References (35)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among Am youth: incidence and prevalence estimates, 2000. Perspect Sex Re- prod Health 2004; 36:6-10.
2. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(suppl 3):S35-S41.
3. Muñoz N, Castellsague X, de Gonzalez AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24(suppl 3):S1-S10.
4. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128-1136.
5. Nielson CM, Harris RB, Dunne EF, et al. Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007; 196:1137-1145.
6. Dinh TH, Sternberg M, Dunne EF, et al. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm Dis 2008; 35:357-360.
7. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papilloma-virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24.
8. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
9. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995; 33:2058 -2063.
10. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928-1943.
11. The Future II Study Group. Quadrivalent vaccine against human papillo-mavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-1927.
12. Block SL, Nolan T, Sattler C, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006; 118:2135-2145.
13. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol 2007; 107(suppl 2):S24-S26.
14. Giuliano AR, Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: point. Cancer Epidemiol Biomarkers Prev 2008; 17:805-808.
15. Trimble CL. Human papillomavirus vaccination should be offered to young males: counterpoint. Cancer Epidemiol Biomarkers Prev 2008; 17:809.
16. Agarwal SS, Sehgal A, Sardana S, et al. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 1993; 72:1666-1669.
17. Zunzunegui MV, King MC, Coria CF, et al. Male influences on cervical cancer risk. Am J Epidemiol 1986; 123:302-307.
18. Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillo-mavirus vaccination strategies. Emerg Infect Dis 2007; 13:28 -41.
19. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007; 34:468 -471.
20. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int 2000; 21:375-391.
21. Kahn JA, Rosenthal SL, Hamann T, et al. Attitudes about human papillo-mavirus vaccine in young women. Int J STD AIDS 2003; 14:300-306.
22. Zimet GD, Mays RM, Winston Y, et al. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000; 9:47-50.
23. Boehner CW, Howe SR, Bernstein DI, et al. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003; 30:774-778.
24. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007; 34:471-485.
25. Marshall H, Ryan P, Roberton D, et al. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. AustNZJPublic Health 2007; 31:235-242.
26. McClelland A, Liamputtong P. Knowledge and acceptance of human pap-illomavirus vaccination: perspectives of young Australians living in Melbourne. Australia Sex Health 2006; 3:95-101.
27. Sauvageau C, Duval B, Gilca V, et al. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec. Canada BMC Public Health 2007; 7:304.
28. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory- informed, systematic review. Prev Med 2007; 45:107-114.
29. Zimet GD, Liddon N, Rosenthal SL, et al. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006; 24(suppl 3):S201-S209.
30. Gerend MA, Shepherd JE. Using message framing to promote acceptance of the human papillomavirus vaccine. Health Psychol 2007; 26:745-752.
31. McPartland TS, Weaver BA, Lee S, et al. Men's perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. J Am Coll Health 2005; 53:225-230.
32. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q 1988; 15:175-183.
33. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008; 42:237-242.
34. Gerend MA, Shepherd JE, Monday KA. Behavioral frequency moderates the effects of message framing on HPV vaccine acceptability. Ann Behav Med 2008; 35:221-229.
35. Tider DS, Parsons JT, Bimbi DS. Knowledge of human papillomavirus and effects on sexual behaviour of gay/bisexual men: a brief report. Int J STD AIDS 2005; 16:707-708.